Health and Healthcare Systems
How the lessons from Ebola helped the COVID-19 response
The COVID-19 pandemic benefitted from the lessons of the Ebola outbreak and a vaccine was developed quickly in comparison. But could drug trials be improved?
Paul Barnsley is Emerging Infectious Disease Lead at Policy Cures Research (PCR), a global health think tank that collects and analyses data on R&D investments and biomedical products that target the world’s most vulnerable populations. He leads on the creation of PCR’s in-depth reports on the landscape of emerging infectious disease R&D, covering funding flows, products and stakeholders.
Paul has over 10 years’ experience as a health economist, which has included work with the United Kingdom’s Office of Health Economics, Deloitte Access Economics and most recently a role as the senior health economist for the Royal Life Saving Society. His work in the health care sector has focused on the pharmaceutical industry, drowning prevention and epidemiology, and valuation of health care interventions.
Earlier in his career, Paul worked in project finance and construction contracting with a major Australian law firm, assisting in the creation of legal and financial structures underlying large infrastructure projects. Paul also worked as a freelance information technology journalist and provided advice to the United Kingdom Charities Aid Foundation on prioritization of corporate philanthropic spending.
Paul’s academic work can be found in the Journal of Technology Assessment in Health, the Journal of Safety Research and BMJ Open.
Most Popular